Status:
COMPLETED
A Registry Study on Primary/idiopathic Triglyceride Deposit Cardiomyovasculopathy
Lead Sponsor:
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Collaborating Sponsors:
Osaka University Graduate School of Medicine
Conditions:
Triglyceride Deposit Cardiomyovasculopathy
Eligibility:
All Genders
20+ years
Brief Summary
The objective of this study is to construct a registry; in order to understand the onset status of triglyceride deposit cardiomyovasculopathy (TGCV) in Japan with patients' background and natural hist...
Eligibility Criteria
Inclusion
- Adult patients who have been confirmed as TGCV based on the diagnostic criteria for TGCV
Exclusion
- The patients who refused to participate in the study by opt-out
Key Trial Info
Start Date :
March 31 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
193 Patients enrolled
Trial Details
Trial ID
NCT05345223
Start Date
March 31 2022
End Date
December 31 2023
Last Update
December 20 2024
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Aichi Medical University
Nagakute, Aichi-ken, Japan, 4801195
2
Nagoya University
Nagoya, Aichi-ken, Japan, 4668560
3
Chiba University Graduate School of Medicine
Chiba, Chiba, Japan, 2608677
4
Kyushu University
Fukuoka, Fukuoka, Japan, 8128582